Steven Gannon's Insider Trades & SAST Disclosures
Steven Gannon's most recent trade in Xenon Pharmaceuticals Inc was a trade of 5,144 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Steven Gannon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc | Steven Gannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 5,144 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Steven Gannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.57 per share. | 14 May 2025 | 5,144 | 7,144 (0%) | 0% | 12.6 | 64,660 | Common Shares |
| Xenon Pharmaceuticals Inc | Steven Gannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 15,542 | 15,542 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Steven Gannon | Director | Sale of securities on an exchange or to another person at price $ 46.25 per share. | 07 Mar 2024 | 5,000 | 9,000 (0%) | 0% | 46.3 | 231,250 | Common Shares |
| Xenon Pharmaceuticals Inc | Steven Gannon | Director | Sale of securities on an exchange or to another person at price $ 46.30 per share. | 07 Mar 2024 | 5,000 | 4,000 (0%) | 0% | 46.3 | 231,513 | Common Shares |
| Xenon Pharmaceuticals Inc | Steven Gannon | Director | Sale of securities on an exchange or to another person at price $ 46.20 per share. | 07 Mar 2024 | 2,000 | 2,000 (0%) | 0% | 46.2 | 92,402 | Common Shares |
| Xenon Pharmaceuticals Inc | Steven Gannon | Director | Sale of securities on an exchange or to another person at price $ 46.45 per share. | 07 Mar 2024 | 1,000 | 14,000 (0%) | 0% | 46.5 | 46,450 | Common Shares |
| Xenon Pharmaceuticals Inc | Steven Gannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 18,475 | 18,475 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Steven Gannon | Director | Purchase of securities on an exchange or from another person at price $ 2.03 per share. | 11 Aug 2022 | 44,400 | 56,400 | - | 2.0 | 90,132 | Common Stock |
| Xenon Pharmaceuticals Inc | Steven Gannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Steven Gannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Steven Gannon | Director | Purchase of securities on an exchange or from another person at price $ 7.99 per share. | 23 Aug 2021 | 2,829 | 12,000 | - | 8.0 | 22,590 | Common Stock |
| Fusion Pharmaceuticals Inc | Steven Gannon | Director | Purchase of securities on an exchange or from another person at price $ 8.05 per share. | 18 Aug 2021 | 3,000 | 9,171 | - | 8.1 | 24,150 | Common Stock |
| Fusion Pharmaceuticals Inc | Steven Gannon | Director | Purchase of securities on an exchange or from another person at price $ 8.05 per share. | 18 Aug 2021 | 171 | 6,171 | - | 8.1 | 1,377 | Common Stock |
| Fusion Pharmaceuticals Inc | Steven Gannon | Director | Purchase of securities on an exchange or from another person at price $ 8.10 per share. | 16 Aug 2021 | 6,000 | 6,000 | - | 8.1 | 48,600 | Common Stock |
| Fusion Pharmaceuticals Inc | Steven Gannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Steven Gannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Steven Gannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 141,011 | 141,011 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Steven Gannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges